Table 1 Baseline patient, socio-demographic and clinical characteristics and geriatric assessment data

Variable

Operationalization

N (%)

95% CI^a

N (%)

95% CI^a

Age (years)

70–74

1212 (21.0)

19.99–22.10

815 (22.1)

20.80–23.48

75–79

1556 (27.0)

25.87–28.17

1007 (27.4)

25.92–28.80

80–84

1668 (29.0)

27.79–30.14

1038 (28.2)

26.74–29.65

≥85

1323 (23.0)

21.87–24.04

821 (22.3)

20.96–23.65

Median

80.0

80.0

Range

70–101

70–100

Sex

Male

2626 (45.6)

44.31–46.88

1601 (43.5)

41.89–45.10

Female

3133 (54.4)

53.12–55.69

2080 (56.5)

54.90–58.11

Diagnosis general

Solid tumor/Carcinoma

5218 (90.6)

89.85–91.36

3352 (91.1)

90.14–91.98

Hematologic malignancy

541 (9.4)

8.64–10.15

329 (8.9)

8.02–9.86

Diagnosis specific

New diagnosis

4488 (77.9)

76.86–79.00

2907 (79.0)

77.66–80.29

Relapse/ Progression

1271 (22.1)

21.00–23.14

774 (21.0)

19.71–22.34

CCI^a

Score 0

1486 (26.0)

24.90–27.18

989 (27.0)

25.58–28.46

Score ≥ 1

4220 (74.0)

72.82–75.10

2671 (73.0)

71.54–74.42

Missing

53

21

Polypharmacy^a

Number 0–4

2052 (36.4)

35.12–37.63

1355 (37.3)

35.71–38.86

Number ≥ 5

3589 (63.6)

62.37–64.88

2279 (62.7)

61.14–64.29

Missing

118

47

ECOG-PS

Score 0–1

2915 (50.6)

49.32–51.91

2098 (57.0)

55.40–58.60

Score 2–4

2844 (49.4)

49.32–51.91

1583 (43.0)

41.40–44.60

Living situation^a

Living alone

2070 (36.0)

34.70–37.18

1307 (35.5)

33.96–37.05

Living with others

3179 (55.2)

53.92–56.49

2080 (56.5)

54.90–58.11

Other

508 (8.8)

8.12–9.59

294 (8.0)

7.11–8.86

Missing

2

0

Professional home care ^a

No

2694 (46.8)

45.55–48.13

1696 (46.1)

44.51–47.72

Yes

3057 (53.2)

51.87–54.45

1982 (53.9)

52.28–55.50

Missing

8

3

FS: ADL (6–24)

Independent: score 6

2329 (40.5)

39.1–41.7

1623 (44.1)

42.5–45.7

Dependent: score ≥ 7

3430 (59.5)

58.0–61.0

2058 (55.9)

54.0–58.0

FS: IADL ^a (0–5 (male)/8(female))

Independent: score 8 (female) or 5 (male)

1817 (31.8)

30.3–32.7

1267 (34.4)

33.0–36.0

Dependent: score < 8 or 5

3902 (68.2)

67.0–69.0

2401 (65.6)

64.0–67.0

Missing

40

13

Pain (VAS) (0–10) ^a

No pain (score 0)

2725 (48.3)

47.0–49.6

1810 (50.1)

48.4–51.7

Mild pain (score 0.5–3)

1086 (19.3)

18.2–20.3

717 (19.8)

18.5–21.1

Severe (score 3.5–10)

1828 (32.4)

31.2–33.6

1087 (30.1)

28.6–31.6

Missing

120

67

Fatigue (VAS) (0–10) ^a

No fatigue (score 0)

1261 (22.7)

21.6–23.8

937 (26.3)

24.8–27.7

Presence of fatigue (score 0.5–10)

4299 (77.3)

76.0–78.0

2632 (73.5)

72.0–75.0

Missing

199

112

Cognition (MMSE) (0–30) ^a

Score ≥ 24 = normal cognition

3942 (76.9)

75.7–78.1

2686 (80.1)

78.8–81.5

Score 18–23 = mild cognitive impairment

831 (16.2)

15.2–17.2

495 (14.8)

13.6–16.0

Score ≤ 17 = severe cognitive impairment

353 (6.9)

6.2–7.6

170 (5.1)

4.3–5.8

Missing

633

330

Depression (GDS) (0–15) ^a

Score 0–4 = not at risk for depression

3301(62.8)

61.5–64.1

2297 (66.8)

65.3–68.4

Score 5–15 = at risk for depression

1954 (37.2)

36.0–38.0

1140 (33.2)

32.0–35.0

Missing

504

244

Nutrition (MNA-SF) (0–14) ^a

Normal nutritional status: score 12–14

1028 (17.9)

16.9–18.9

760 (20.7)

19.4–22.0

Risk of malnutrition: score 8–11

2986 (52.0)

50.7–53.3

2022 (55.1)

53.4–56.6

Malnourished: score 0–7

1728 (30.1)

28.9–31.3

891 (24.2)

22.9–25.6

Missing

17

8